![Richard Kincaid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Kincaid
Finanzdirektor/CFO bei
HEALIOS K.K.
Vermögen: 336 971 $ am 31.08.2026
Profil
Richard Patrick Kincaid is currently Chairman, President & Chief Executive Officer at Healios N.A., Inc. since 2023.
He is an Outside Director at Metaplanet, Inc. starting in 2025.
He serves as Chief Financial Officer & Director at Healios KK since 2019 and is a Board Manager at Saisei Ventures LLC.
Formerly, Mr. Kincaid was Director at Nezu Master Strategy Feeder Ltd. He was Chief Operating Officer & Partner at Nezu Asia Capital Management Ltd. from 2011 to 2013.
From 2003 to 2019, he was COO & Management Committee Member at Nezu Asia Capital Management (Singapore) Pte Ltd. Mr. Kincaid completed undergraduate studies at Harvard University in 1999.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HEALIOS KK 0,14 % | 31.12.2025 | 187.500 ( 0,14 % ) | 336 971 $ | 31.08.2026 |
Aktive Positionen von Richard Kincaid
| Unternehmen | Position | Beginn |
|---|---|---|
| HEALIOS K.K. | Finanzdirektor/CFO | 16.07.2019 |
| METAPLANET INC. | Direktor/Vorstandsmitglied | 24.03.2025 |
Healios N.A., Inc. | Vorstandsvorsitzender | - |
Saisei Ventures LLC
 Saisei Ventures LLC Investment ManagersFinance Saisei Ventures invests in companies located across the globe. The firm focuses on the biotechnology sector with a focus on advanced therapies such as cell and gene therapies and regenerative medicines. It participates in seed and early stage transactions. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Richard Kincaid
| Unternehmen | Position | Ende |
|---|---|---|
Nezu Asia Capital Management (Singapore) Pte Ltd.
 Nezu Asia Capital Management (Singapore) Pte Ltd. Investment ManagersFinance Nezu Asia SG’s investment philosophy is based on GARP and focuses on growth and capital efficiency, primarily in the business process outsourcing (including software), MedTech, and consumer sectors. Their portfolio is micro, fundamental, and backed up by several hundred company visits per annum as the cornerstone of the investment process. | Präsident | 01.12.2019 |
Nezu Master Strategy Feeder Ltd.
 Nezu Master Strategy Feeder Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as hedge fund | Direktor/Vorstandsmitglied | - |
Nezu Asia Capital Management Ltd.
 Nezu Asia Capital Management Ltd. Investment ManagersFinance Nezu HK is an active manager which aims to achieve high risk-adjusted returns for investors through fundamental research, their market experience and risk management process. | Geschäftsführer | - |
Ausbildung von Richard Kincaid
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metaplanet, Inc.
 Metaplanet, Inc. Investment Banks/BrokersFinance Operates as a holding company whose subsidiaries provides bitcoin treasury services and operates hotels | Finance |
Nezu Asia Capital Management Ltd.
Nezu Asia Capital Management Ltd. Investment ManagersFinance Nezu HK is an active manager which aims to achieve high risk-adjusted returns for investors through fundamental research, their market experience and risk management process. | Finance |
Nezu Asia Capital Management (Singapore) Pte Ltd.
Nezu Asia Capital Management (Singapore) Pte Ltd. Investment ManagersFinance Nezu Asia SG’s investment philosophy is based on GARP and focuses on growth and capital efficiency, primarily in the business process outsourcing (including software), MedTech, and consumer sectors. Their portfolio is micro, fundamental, and backed up by several hundred company visits per annum as the cornerstone of the investment process. | Finance |
Healios KK
 Healios KK Pharmaceuticals: MajorHealth Technology Engages in the research, development and manufacture of cell therapy and regenerative medicine products | Health Technology |
Nezu Master Strategy Feeder Ltd.
Nezu Master Strategy Feeder Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as hedge fund | Miscellaneous |
Healios N.A., Inc. | |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures invests in companies located across the globe. The firm focuses on the biotechnology sector with a focus on advanced therapies such as cell and gene therapies and regenerative medicines. It participates in seed and early stage transactions. | Finance |
